A Royal College of Physicians report found that cancer patients at University Hospitals Coventry and Warwickshire NHS trust were harmed by years of unnecessary chemotherapy. The review examined the care of 20 brain tumour patients treated by retired clinical oncologist Prof Ian Brown.
The review was commissioned after colleagues raised concerns when Brown’s patients were handed over following his retirement in 2023. It found that patients received long-term repeated cycles of temozolomide (TMZ), far beyond the usual course, without evidence that continuing treatment would benefit them. Some remained on chemotherapy despite their cancer progressing, when supportive care for their symptoms would have been a better choice.
Fifteen of the 20 cases were judged to involve unsatisfactory care, while five were graded as requiring improvement. The report said some patients were misdiagnosed and given inappropriate treatment. Others were incorrectly told they would die if they stopped chemotherapy.
One patient received more than 10 years of chemotherapy after being told they had deadly glioblastoma. The diagnosis was later found to be grade-1 pilocytic astrocytoma, a low-grade tumour with potentially normal life expectancy that does not require chemotherapy. Another patient received chemotherapy for a decade and experienced “significant toxicity”, including fatigue, nausea, severe shingles requiring hospital admission, and nausea and vomiting.
The trust’s leaders have apologised. The legal firm Brabners, which represents more than 40 patients, is calling for an independent public inquiry. The report recommends that the trust arrange independent reviews for all living patients who received more than 12 cycles of TMZ.
Becky Jones received more than 100 cycles of chemotherapy over 10 years after being incorrectly diagnosed with grade-4 glioblastoma and told she had between six and 12 months to live.
“For years, I questioned why I was still being given chemotherapy when my scans were stable, but I was repeatedly told that without it I would die,” Jones said. She said the report’s confirmation of serious failings was “validating” but “incredibly painful”, given the opportunities to review patients’ care. “I now need a full and honest explanation of what happened to me,” she said.
Prof Andy Hardy, the trust’s chief executive, and Sue Noyes, its chair, said they were “deeply sorry to all the patients and families affected by failures within our neuro-oncology service under the care of retired clinical oncologist Ian Brown”.
They said: “We recognise the concern, distress and loss of trust experienced by those who placed their faith in us during some of the most difficult moments of their lives. While an apology alone cannot undo the issues experienced, we are clear that meaningful action is being taken.
“These findings make for extremely difficult reading and raise serious questions about individual clinical decisions and historical governance. We will learn from this openly, transparently and with the utmost urgency.”
